Products

Bislor

Bislor

Generic Name Bilastine
Preparation Each film coated tablet contains Bilastine INN 20 mg.
Therapeutic Class Antihistamine

Indications

Allergic Rhinitis: Bilastine is indicated for the symptomatic relief of allergic rhinitis. Allergic Rhino conjunctivitis: Bilastine is indicated for the relief of the symptoms associated with allergic rhino conjunctivitis. Urticaria: Bilastine is indicated for the relief of the symptoms associated with urticaria (e.g. pruritus).

Dosage & Administration

Adults & adolescents (12 years of age and over): 20 mg tablet once daily for symptomatic relief of allergic rhinitis, urticaria and allergic rhinoconjunctivitis. The maximum recommended daily dose is 20 mg Bilastine (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken.

Contraindications

Bilastine is contraindicated in patients with: Hypersensitivity to Bilastine or to any ingredient in the formulation or component of the tablet.

Overdosage

Information regarding acute overdose of Bilastine is retrieved from the experience of clinical trials conducted during the development and the post-marketing surveillance. No serious adverse events and no significant prolongation in the QT interval were reported. The information collected in the post-marketing surveillance is consistent with that reported in clinical trials.